aTyr Pharma, Inc. ATYR
3.69 USD -0.39 (-9.56%)
Regular-session close
3.70 +0.01 +0.27%
After hours · Nov 19, 4:12 PM ET
3.69 Day range 4.21
3.69 52-week range 44.40
- YTD
- -88.22%
- 1 year
- -86.33%
News
benzinga.com aTyr Pharma Files ~$80M At-The-Market Offering To Sell Common Stock Through Jefferies On November 6, 2026, aTyr Pharma, Inc. (the "Company") filed a prospectus supplement (the "Prospectus Supplement") related to the sale of the Company’s common stock, par value $0.001 per share (the
benzinga.com RBC Capital Maintains Sector Perform on aTyr Pharma, Lowers Price Target to $6 RBC Capital analyst Brian Abrahams maintains aTyr Pharma (NASDAQ:ATYR) with a Sector Perform and lowers the price target from $40 to $6.
benzinga.com Wells Fargo Maintains Equal-Weight on aTyr Pharma, Raises Price Target to $4 Wells Fargo analyst Derek Archila maintains aTyr Pharma (NASDAQ:ATYR) with a Equal-Weight and raises the price target from $1 to $4.
benzinga.com aTyr Pharma Q3 EPS $(7.43) Misses $(4.00) Estimate aTyr Pharma (NASDAQ:ATYR) reported quarterly losses of $(7.43) per share which missed the analyst consensus estimate of $(4.00) by 85.75 percent. This is a 2757.69 percent decrease over losses of…
benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session Gainers Curis (NASDAQ:CRIS) shares moved upwards by 61.8% to $1.16 during Wednesday's regular session. The market value of their outstanding shares is at $1.7 million. Lyell Immunopharma…benzinga.com aTyr Pharma Announces 1-For-40 Reverse Stock Split, Effective Oct. 28 aTyr Pharma, Inc. (Nasdaq: ATYR) ("aTyr" or the "Company"), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA
benzinga.com aTyr Pharma Enters Research Collaboration With Albert Einstein College Of Medicine To Develop And Test ATYR2810, Its Monoclonal Antibody That Targets The Neuropilin-2 Receptor The collaboration will be led by Bang H. Hoang, M.D., Arnold and Madaleine Penner Professor and Co-Director of Orthopaedic Oncology in the Department of Orthopaedic Surgery at Montefiore Einstein.…
